Severe cognitive impairment

Bausch + Lomb and Glaucoma Research Foundation Announce Launch of Screen, Protect, Cure Campaign In Recognition of Glaucoma Awareness Month

Retrieved on: 
Tuesday, January 3, 2023
Health, Optical, Severe cognitive impairment, GRF, Bausch & Lomb, Eye disease, Research, Glaucoma, Organization, Breast Cancer Awareness Month, Risk, Patient, NYSE, Pharmaceutical industry

Through ‘Screen, Protect, Cure,’ we hope to help support patients in every step of their treatment journey.”1

Key Points: 
  • Through ‘Screen, Protect, Cure,’ we hope to help support patients in every step of their treatment journey.”1
    During the month of January, Glaucoma Awareness Month, Bausch + Lomb and GRF will share educational resources to educate individuals who may be at risk for glaucoma and empower them to take an informed and active role in their eye health.
  • The campaign also features a fundraising challenge that will match every dollar raised up to $20,000 in support of GRF research for a potential cure for glaucoma.
  • “Glaucoma Awareness Month provides a great opportunity to share information about this sight-threatening disease and remind people there are steps they can take to help preserve their vision,” said Thomas M. Brunner, president & CEO, GRF.
  • Although there is currently no cure, our fight to prevent visual disability is ongoing, and we are grateful for the collaboration of organizations, such as Bausch + Lomb, who share this commitment with us.”

Ophthalmic Lasers Global Market Report 2022: Increasing Regulatory Approvals for Ophthalmic Lasers Bolsters Sector - ResearchAndMarkets.com

Retrieved on: 
Wednesday, December 28, 2022
Optical, Health, Surgery, Medical Devices, Cataract, Myopia, Laser, Severe cognitive impairment, Food, Approximation error, Research, COVID-19, Surgeon, USD, Contoura Vision, Annals of Medicine, Patient, Otto, Picolo, US Foods, Medicine, World Economic Forum, Presbyopia, FDA, SMILE, Prevalence, WHO, Woman, Medical device, LASIK, Growth

The "Ophthalmic Lasers Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Ophthalmic Lasers Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)" report has been added to ResearchAndMarkets.com's offering.
  • The large prevalence of ophthalmic disorders around the world is adding to the growth of the ophthalmic lasers market.
  • The increasing prevalence of ophthalmic lasers in refractive error corrections is expected to aid the growth of the segment in the ophthalmic lasers market during the forecast period.
  • Thus the increasing necessity for surgeries involving ophthalmic lasers and increasing research and development in the healthcare department are known to propel the growth of the market in this region.

Mediaplanet and Operation Sight Are Bringing Awareness to Accessibility and Vision Care

Retrieved on: 
Friday, January 6, 2023
Cataract, Social media, Elective surgery, News, Severe cognitive impairment, Ophthalmology, Insurance, USA Today, American Society of Cataract and Refractive Surgery, ASCRS, Society, Hospital, Veterinary medicine, Central Florida

FAIRFAX Va., Jan. 6, 2023 /PRNewswire-PRWeb/ -- As of 2018, more than 32 million Americans are experiencing vision loss, and more than 24 million people over the age of 40 have cataracts specifically. The good news is cataract surgery is a safe and effective treatment; the bad news is it can cost as much as $6,000 per eye for those without insurance.

Key Points: 
  • U.S. based charitable cataract surgery program, Operation Sight, connects under- and uninsured who cannot afford to pay for cataract surgery to a nationwide network of volunteer surgeons.
  • Operation Sight is a U.S.-based charitable cataract surgery program launched in 2014 by The American Society of Cataract and Refraction Surgery (ASCRS).
  • The program connects under- and uninsured people who cannot afford to pay for cataract surgery to a nationwide network of volunteer surgeons.
  • Operation Sight depends on support from donors to continue funding these costly but important surgeries, and the annual Gift of Sight fundraising campaign is a chance to change someone's life.

NIH-Sponsored Internship to Diversify Future Healthcare Workforce at UC San Diego

Retrieved on: 
Friday, January 6, 2023
Diabetes, Severe cognitive impairment, Health, USCD, Assistant, Research, CDC, Artificial intelligence, UC San Diego Health, Biomarker, Workforce, Conditional sentence, SAN, Disease, Visual impairment, AI, Learning, Diabetic retinopathy, Centers for Disease Control and Prevention, University, Master of Science, University of California, San Diego, UCSD, Statistics, NIH, Biomedical Research, UC, Stockholm Environment Institute US Center, Intelligence, Medical device, Fashion, MD, Ophthalmology

SAN DIEGO, Jan. 6, 2023 /PRNewswire-PRWeb/ -- Exposing the next generation of professionals in healthcare settings to the intersection of artificial intelligence (AI) and the biomedical sciences is crucial to diversifying that workforce. To promote that diversity, the University of California San Diego (USCD) Viterbi Family Department of Ophthalmology and Shiley Eye Institute have announced the AI Ready and Equitable Atlas for Diabetes Insights (AI-READI) Yearlong Research Internship Program.

Key Points: 
  • An NIH-funded program offers a yearlong paid internship focused on diversifying the future workforce at the intersection of healthcare and AI.
  • SAN DIEGO, Jan. 6, 2023 /PRNewswire-PRWeb/ -- Exposing the next generation of professionals in healthcare settings to the intersection of artificial intelligence (AI) and the biomedical sciences is crucial to diversifying that workforce.
  • To promote that diversity, the University of California San Diego (USCD) Viterbi Family Department of Ophthalmology and Shiley Eye Institute have announced the AI Ready and Equitable Atlas for Diabetes Insights (AI-READI) Yearlong Research Internship Program.
  • This yearlong paid internship is focused on diversifying the healthcare workforce in biomedical sciences and AI and speed up the widespread use of AI in biomedical research and healthcare.

Mediaplanet and RxSight® Team Up to Bring Awareness to Eye Health and Vision Care

Retrieved on: 
Friday, January 6, 2023
Lens, Social media, LAL, Severe cognitive impairment, Patient, Cataract, Ophthalmology, USA Today, Surgery, Telescopic sight, Central Florida

ALISO VIEJO, Calif., Jan. 6, 2023 /PRNewswire-PRWeb/ -- Approximately 32 million Americans reported experiencing vision loss in 2018, and more than half of all Americans will have cataracts by age 80. Luckily, cataract surgery is effective and safe, with 90% of patients reporting improved vision. However, many people report that their post-surgery vision isn't as good as they'd hoped.

Key Points: 
  • Luckily, cataract surgery is effective and safe, with 90% of patients reporting improved vision.
  • However, many people report that their post-surgery vision isn't as good as they'd hoped.
  • The Light Adjustable LensTM (LAL®) by RxSight® is aiming to fix this dilemma by allowing you to test drive your post-cataract surgery vision.
  • The Light Adjustable Lens is a game changer for anyone dealing with cataracts, or anyone concerned for their overall eye health.

Mediaplanet and Lightbody Team Up to Bring Awareness to Eye Health and Vision Care

Retrieved on: 
Friday, January 6, 2023
Social media, Eye, GMO, Risk, Digital, Severe cognitive impairment, Learning, Nutrient, GLARE, Ophthalmology, USA Today, Cornea, Retina, Cosmetics, Central Florida, Lightbody

ST. PETERSBURG, Fla., Jan. 6, 2023 /PRNewswire-PRWeb/ -- In a post-pandemic world, eye care has become increasingly important as more and more people are working or learning in a hybrid or remote environment, increasing screentime to levels never seen before. The concern is that blue light emitted by device screens can be very harmful to our eyes, even though we might not always notice the damage. Chronic blue light exposure can lead to potential damage to the retina or cornea, accelerated eye aging, lack of eye moisture, and eye strain or glare. Although many eye diseases are life-altering in later stages, many have little to no symptoms in the early stages, making eye care – as well as eye maintenance – essential to modern life.

Key Points: 
  • Mediaplanet's Vision Care campaign, found within USA TODAY and online, showcases personal stories and provides resources to help fight against the global vision crisis.
  • Chronic blue light exposure can lead to potential damage to the retina or cornea, accelerated eye aging, lack of eye moisture, and eye strain or glare.
  • Although many eye diseases are life-altering in later stages, many have little to no symptoms in the early stages, making eye care – as well as eye maintenance – essential to modern life.
  • That's why Lightbody developed Total Eye Health + Blue Light Defense, a supplement that provide nutrients to maintain retinal and macular health while filtering blue light and other high-energy light.

Perceive Biotherapeutics Attracts $78M Series B Financing to Advance Diversified Pipeline

Retrieved on: 
Thursday, January 5, 2023
Severe cognitive impairment, Glaucoma, LP, Science, SAN, Iovance Biotherapeutics, Patient, Therapy, Geographic atrophy, Pharmaceutical industry, Ophthalmology

SOUTH SAN FRANCISCO, Calif., Jan. 5, 2023 /PRNewswire/ -- Perceive Biotherapeutics, a biotech company pioneering novel technologies and therapeutics in ophthalmology, today announced the closing of a $78M Series B funding round led by Johnson & Johnson Innovation – JJDC, Inc.(JJDC), joining existing Series A investor Deerfield Management and new investors  Braidwell LP, the Retinal Degeneration Fund, and Catalio Capital Management, LP. 

Key Points: 
  • Perceive Biotherapeutics Attracts $78M Series B Financing to Advance Diversified Pipeline in Ophthalmology.
  • Perceive Biotherapeutics is focused on the discovery and development of transformative gene therapies and other therapeutics for ocular diseases with high unmet need.
  • By leveraging deep genetic understandings, Perceive Bio researchers have elucidated key protective biological targets.
  • Perceive Bio is advancing therapeutic programs in geographic atrophy / age-related macular degeneration, glaucoma, and additional undisclosed disease areas.

Verana Health and Sight Sciences Collaborate on Glaucoma Research Using Curated Real-World Data from the IRIS Registry

Retrieved on: 
Wednesday, January 4, 2023
Exocrine gland, SAN, HCP, Optic nerve, Surgical instrument, Duane syndrome, Safety, Diabetic retinopathy, Health, Research, American Academy, Intraocular pressure, Patient, Trabecular meshwork, American Academy of Ophthalmology, American Academy of Neurology, PARK, IOP, Machine Intelligence Research Institute, Glaucoma, FDA, State, Geographic atrophy, Trauma, MD, Data management, American Urological Association, Severe cognitive impairment, Database, Doctor of Philosophy, RWD, MIGS, Quality of life, Surgeon, Catheter, HCPS, Laika (EHR testing framework), Medicine, Eye, IRIS, OMNI, MGD, Physician, Cataract, Pharmaceutical industry, Dentistry, Medical imaging, Medical device, Ophthalmology

SAN FRANCISCO and MENLO PARK Calif., Jan. 4, 2023 /PRNewswire/ -- Verana Health®—a digital health company elevating quality in real-world data (RWD)—and Sight Sciences, Inc. (NASDAQ: SGHT), an eyecare technology company focused on creating innovative solutions intended to transform care and improve patients' lives, today announced a research collaboration designed to provide insights that may lead to improved outcomes for patients with primary open-angle glaucoma (POAG).

Key Points: 
  • Powered by real-world glaucoma data curated from the American Academy of Ophthalmology (Academy) IRIS® Registry (Intelligent Research in Sight), Qdata Glaucoma is the only data module that captures the full, real-world glaucoma patient journey.
  • This fit-for-purpose data module offers curated data for:
    The IRIS Registry is one of the largest specialty society clinical data registries in all of medicine and the first comprehensive eye disease clinical registry in the U.S.
  • Michael Mbagwu, MD, senior medical director for Verana Health says, "Sight Sciences shares our goal of improving outcomes and treatments for people with glaucoma.
  • Using its clinician-informed and artificial intelligence-enhanced VeraQ® population health data engine, Verana Health transforms structured and unstructured healthcare data into curated, disease-specific data modules, Qdata®.

Prevent Blindness Issues Call for Nominations for the 2023 Jenny Pomeroy Award for Excellence in Vision and Public Health, and Rising Visionary Award

Retrieved on: 
Wednesday, January 4, 2023
Eye, School, University, Massachusetts Eye and Ear, Public health, Head, Research, UAB, Ohio Department of Health, Master of Science, FACS, OD, United States Department of Veterans Affairs, Research to Prevent Blindness, New England College, University of Illinois Urbana-Champaign, Veterans' affairs, Visual Science, Illinois Eye and Ear Infirmary, DPA, University college, Visual impairment, MBA, Doctor of Philosophy, Professor, Policy, Ear, Johns Hopkins University, Severe cognitive impairment, Essay, New England College of Optometry, ROP, University of Alabama, Bascom Palmer Eye Institute, UIC, New England, Pharmaceutical industry, Management, Optometry, Ophthalmology, MD, Child, MPH

CHICAGO, Jan. 4, 2023 /PRNewswire-PRWeb/ -- Prevent Blindness, the nation's oldest volunteer eye health and safety organization, is issuing the call for nominations for the "2023 Jenny Pomeroy Award for Excellence in Vision and Public Health," and the fourth annual "Rising Visionary Award." Both awards will be formally presented at the 12th Annual Prevent Blindness Focus on Eye Health National Summit, on July 12-13, 2023.

Key Points: 
  • Both awards will be formally presented at the 12th Annual Prevent Blindness Focus on Eye Health National Summit, on July 12-13, 2023.
  • The highest honor that Prevent Blindness bestows, the award is a tribute to Jenny Pomeroy, who was the CEO of Prevent Blindness Georgia from 1996 until 2013, and an accomplished leader in advancing public health and policy for vision and eye health issues.
  • The recipient of the 2022 Jenny Pomeroy Award for Excellence in Vision and Public Health was VOSH/International, a volunteer-based organization.
  • For more information on the Prevent Blindness Jenny Pomeroy Award for Excellence in Vision and Public Health, please visit https://preventblindness.org/jenny-pomeroy-award-for-excellence-in-visio... .

The Worldwide Automated Visual Field Analyzer Industry is Expected to Reach $227.8 Million by 2028: Rapid Technological Advancement and Developments in Analyzer Technology Drives Growth

Retrieved on: 
Wednesday, January 4, 2023
Light, Trauma, Analyser, Patient, Pathology, Neoplasm, Brain, Optometry, Static, Head, Peripheral vision, Health, Disease, Element, COVID-19, Diagnosis, Glaucoma, Stroke, Artificial intelligence, Severe cognitive impairment, Field line, AMD, Movement, Database, Algorithm, Ophthalmology, Swedish interactive thresholding algorithm, SITA, Medical imaging, Medical device, Inspection, Scotoma

The Global Automated Visual Field Analyzer Market size is expected to reach $227.8 Million by 2028, rising at a market growth of 7.0% CAGR during the forecast period.

Key Points: 
  • The Global Automated Visual Field Analyzer Market size is expected to reach $227.8 Million by 2028, rising at a market growth of 7.0% CAGR during the forecast period.
  • An automated visual field analyzer is an automated tool that is very frequently employed by Optometrists, orthoptists, and ophthalmologists to measure the human visual field, especially to identify monocular visual fields.
  • The turnaround time for automated visual field analyzers has greatly decreased, and accuracy in visual field testing has increased in contrast to recent years.
  • Despite a number of benefits of an automated visual field analyzer, there is a major drawback of this technology.